Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Crossing Over01:30

Crossing Over

4.7K
Crossing over is the exchange of genetic information between homologous chromosomes during prophase I of meiosis I. Genetic recombination gives rise to allelic diversity in the newly formed daughter cells. In humans, crossing over produces genetically distinct haploid egg and sperm cells that undergo fertilization to produce unique offspring. Before cell division starts, the germ cell’s chromosome(s) undergo duplication in the S phase of the cell cycle. As the cells enter prophase I,...
4.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
Homologous Recombination02:31

Homologous Recombination

4.9K
4.9K
Mismatch Repair01:20

Mismatch Repair

5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Re: "Does tattoo exposure increase the risk of cutaneous melanoma? A population-based case-control study".

European journal of epidemiology·2026
Same author

Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.

British journal of cancer·2026
Same author

DRIVE v3: Command Line Application for Identity-by-Descent Haplotype Clustering in Large Biobank Scale Data.

Genetic epidemiology·2026
Same author

Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use.

British journal of cancer·2026
Same author

Endothelial cell-specific DNA methylation alterations in breast cancer.

Communications biology·2026
Same author

Associations Between Tattooing and Health Status: A Population-Based Cross-Sectional Study of Adults in Utah, 2020-2022.

Public health reports (Washington, D.C. : 1974)·2026

関連する実験動画

Updated: Sep 9, 2025

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Published on: February 24, 2023

1.8K

自己報告された人種による卵巣高度血清性がんにおける同類再結合欠乏症と生存率

Katherine A Lawson-Michod1, Courtney E Johnson2, Mollie E Barnard3

  • 1Fred Hutchinson Cancer Center, Seattle, WA, United States.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
|September 4, 2025
PubMed
まとめ

ホモローグな再結合欠乏症 (HRD) は卵巣がんの生存率に異なった影響を及ぼします. 多様な集団におけるHRDの特徴づけは 公平な精密医療と改善された結果にとって極めて重要です

さらに関連する動画

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.7K

関連する実験動画

Last Updated: Sep 9, 2025

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Published on: February 24, 2023

1.8K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.7K

科学分野:

  • ゲノム医学
  • 腫瘍学
  • 人口の健康

背景:

  • 卵巣高度血清性がんの半分は同種の再結合欠乏症 (HRD) を表している.
  • HGSCの生存率が低い黒人の場合 HRDの理解は少ない.
  • HGSCの成果の差異は,HRDの人種差異に関する研究を必要とします.

研究 の 目的:

  • 卵巣HGSCにおけるHRDの特徴を特徴づけるために.
  • 黒人と白人の生存率との関連を調べる
  • 人権開発の特徴と臨床的影響における人種差異を特定する.

主な方法:

  • HGSCコホートにおけるHRDの特徴を特定するために,全エクソームとRNAシーケンスを使用した.
  • 生存分析は,年齢とステージに調整された危険比率を使用して,自己報告された人種によって分層化されました.
  • ゲルムラインと体内の変異は,アノテーションと重要性における人種的差異を分析した.

主要な成果:

  • 黒人の死亡リスクは32%,白人の死亡リスクは62%と関連していた.
  • 黒人個体では,注釈されていないまたは不確実な重要性 (VUS) の変種 (65%対45%) と体性変種 (62%対50%) の割合が高く見られた.
  • ゲルムラインが表記されていない/VUSの変種を持つ黒人は,HRDの傷つきと乳がんや卵巣がんの家族歴を持つ可能性がより高かった.

結論:

  • HRD検査は卵巣がんの精密医療に不可欠ですが,黒人の人の高いVUS率は治療へのアクセスを妨げる可能性があります.
  • ゲノム研究では 多様な参加者の採用を優先して VUSを正確に特徴付け,結果の格差を減らす必要があります.
  • 公平ながん治療のための多様な集団におけるVUSの臨床的影響を理解し,対処するためにさらなる研究が必要です.